Videos

Patients with cancer often experience loneliness, and the COVID-19 pandemic helped the general public better understand what that isolation felt like, an expert said.

As part of its Speaking Out video series, CURE spoke with Monica Fawzy Bryant, Esq., from Triage Cancer, about how to better manage medical bills following a cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about choosing and using health insurance before, during and after a cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about policies around taking extended time off from work for patients with cancer and their caregivers.

As part of its Speaking Out video series, CURE spoke with Monica Fawzy Bryant, Esq.,, from Triage Cancer, about planning ahead after a cancer diagnosis.

The second installment of CURE®’s Open Mic Showcase features cancer survivors performing original songs, showcasing a handmade deck of cards and reading poetry.

Research showed a survival improvement in adolescent and young adult cancer survival after the Dependent Care Expansion allowed patients to be on their parents’ insurance until the age of 26.

From music to poetry and dynamic storytelling, the first installment of CURE®’s Open Mic Showcase highlights the talents of patients and survivors of cancer.

Men with low-risk prostate cancer can usually safely forego treatment as long as they continue to monitor their disease with their clinicians, an expert said.

One scientific development can lead to many more for patients with myeloproliferative neoplasms, a type of rare blood cancer, according to an expert.

After a patient is diagnosed with a rare disease such as a myeloproliferative neoplasm, learning about their condition and seeking expert clinicians can help put their mind at ease.

Among patients who held ice in their mouth before, during and after chemotherapy, 78% did not experience oral mucositis.

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.

Dr. Naveen Pemmaraju outlines three reasons why he feels that there is “a momentum that’s unmistakable,” in the field of myeloproliferative neoplasms.

Experts on chronic lymphocytic leukemia discuss how to approach cost considerations and available resources for CLL treatments.

Insights on supportive care and approaches to managing adverse effects of BTK inhibitors in the treatment of chronic lymphocytic leukemia.

Mayra Andujar Delgado does not shy away from discussing her myelofibrosis diagnosis. In fact, the survivor becomes empowered by sharing her knowledge with others.

CLL expert Lori A. Leslie, MD, gives a comprehensive overview of the ALPINE and ELEVATE-RR head-to-head studies of BTK inhibitors in CLL.

Lori A. Leslie, MD, an expert on CLL, talks about factors that influence treatment decisions.

After the COVID-19 pandemic broadened usage of telehealth, patients with myeloma now have more access to experts in their disease.

CLL experts offer insights on shared decision-making with patients while selecting treatments.

Lori A. Leslie, MD, an expert on chronic lymphocytic leukemia, provides a comprehensive overview of BTK inhibitors used in the treatment of CLL.

There are certain side effects from Elahere — a newly approved ovarian cancer drug — that patients taking the treatment should look out for, an expert said.

Hoshiyuki Iida, APN, discusses his role in the multidisciplinary team in the treatment of patients with chronic lymphocytic leukemia.

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process.

Watch Dr. Rupesh Kotecha, from Miami Cancer Institute, Baptist Health South Florida, discuss the treatment of brain metastases during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Ana C. Sandoval Leon, from Miami Cancer Institute, Baptist Health South Florida, discuss HER2-positive metastatic disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

In this Educated Patient® webinar, CURE® spoke with experts from Allegheny Health Network about addressing disparities in diversity, equity and inclusion in cancer care.

Watch Dr. Naomi Dempsey, from Miami Cancer Institute, discuss the management of HER2-positive, early-stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.